Todos Medical Trademarks Tollovid for Dietary Supplement NLC-001 and Enters Into Private Label & Distribution Agreement With The Alchemists Kitchen
Tollovid is a proprietary blend of plant extracts administered orally as dietary supplement
The US FDA granted a Certificate of Free Sale for Tollovid on August 28, 2020
Tollovid ingredients inhibit the 3CL protease, a key protease required for coronavirus replication
The Alchemist’s Kitchen will launch Tollovid in November 2020
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has selected the brand name “Tollovid™” for its proprietary, patent protected 3CL protease inhibitor, previously called NLC-001. Todos licensed the exclusive worldwide distribution rights for Tollovid, excluding Israel, from Israel-based joint venture partner NLC Pharma in September 2020. Tollovid is an orally administered proprietary blend of plant extracts that includes a powerful 3CL protease inhibitor that helps support and maintain healthy immune function. The 3CL protease plays a vital role in the intracellular replication of coronaviruses, and 3CL protease inhibition is being evaluated as a potential therapeutic target for COVID-19 by several groups, including Pfizer.
Concurrent with this announcement, the Company announced that it has entered into a private label and distribution agreement with The Alchemist’s Kitchen, based in the SoHo district of New York City with a significant online presence. The Alchemist’s Kitchen is New York’s leading botanical wellness destination, leveraging the power of plants to improve health while working closely with leading clinicians and medical doctors to educate patients on how to use natural remedies to improve their health in the face of illness or disease. The Alchemist’s Kitchen has been featured in several high-profile educational series, including Dr. Sanjay Gupta’s CBD and cannabis specials that were previously featured on CNN. The Alchemist’s Kitchen will sell Tollovid under its Plant Alchemy™ brand and will train its herbalists to help educate consumers on how adding Tollovid to their immune boosting strategy could potentially lead to improved outcomes in the face of circulating coronaviruses.
“Tollovid certainly is a unique asset in the botanical wellness space, and we are very pleased to be the first to bring this product to market in the United States,” said Lou Sagar, President & CEO of The Alchemist’s Kitchen. “It’s clear there has been a tremendous amount of science developed around Tollovid as it relates to 3CL inhibition, and we believe this could be an important mechanism during this critical time heading into the colder months of the year where people will congregate indoors more often. As a brand, The Alchemist’s Kitchen is always looking to be on the cutting edge of innovation in the botanical wellness space, and Tollovid certainly reinforces our market leading position.”
“We are excited to have selected the brand name Tollovid™ for NLC-001 and to be partnering with The Alchemist’s Kitchen to bring this important immune-boosting dietary supplement into the marketplace at this critical time in the United States,” said Gerald E. Commissiong, President & CEO of Todos Medical. “Some of the most promising data in the scientific literature to date in combatting coronaviruses has been generated by dietary supplements that help reinforce the body’s ability to respond to potential challenges from a coronavirus infection. We are targeting Tollovid to be added to this immune-boosting paradigm, and believe Tollovid could be an important part of an immune boosting strategy to help support and maintain a healthy immune system during this upcoming period of significant concern about potential circulating viruses heading into the colder weather months ahead.”
For information related to Todos Medical’s COVID-19 testing capabilities, please visit www.todoscovid19.com
For testing and PPE inquiries, please email sales@todosmedical.com.
About Tollovid™
Tollovid is an orally administered proprietary blend of plant extracts that includes a powerful 3CL protease inhibitor that helps support and maintain healthy immune function.
About The Alchemist’s Kitchen
The Alchemist's Kitchen is a plant-based wellness brand dedicated to the education of consumers to the potential benefits of botanical medicines and herbal remedies. It develops and markets proprietary formulations via retail and online channels of distribution. The Alchemist’s Kitchen flagship storefront is located at 119 Crosby St, New York, NY 10003. The Company’s website is www.thealchemistskitchen.com.
https://investor.todosmedical.com/news-events...supplement
Tollovid is a proprietary blend of plant extracts administered orally as dietary supplement
The US FDA granted a Certificate of Free Sale for Tollovid on August 28, 2020
Tollovid ingredients inhibit the 3CL protease, a key protease required for coronavirus replication
The Alchemist’s Kitchen will launch Tollovid in November 2020
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has selected the brand name “Tollovid™” for its proprietary, patent protected 3CL protease inhibitor, previously called NLC-001. Todos licensed the exclusive worldwide distribution rights for Tollovid, excluding Israel, from Israel-based joint venture partner NLC Pharma in September 2020. Tollovid is an orally administered proprietary blend of plant extracts that includes a powerful 3CL protease inhibitor that helps support and maintain healthy immune function. The 3CL protease plays a vital role in the intracellular replication of coronaviruses, and 3CL protease inhibition is being evaluated as a potential therapeutic target for COVID-19 by several groups, including Pfizer.
Concurrent with this announcement, the Company announced that it has entered into a private label and distribution agreement with The Alchemist’s Kitchen, based in the SoHo district of New York City with a significant online presence. The Alchemist’s Kitchen is New York’s leading botanical wellness destination, leveraging the power of plants to improve health while working closely with leading clinicians and medical doctors to educate patients on how to use natural remedies to improve their health in the face of illness or disease. The Alchemist’s Kitchen has been featured in several high-profile educational series, including Dr. Sanjay Gupta’s CBD and cannabis specials that were previously featured on CNN. The Alchemist’s Kitchen will sell Tollovid under its Plant Alchemy™ brand and will train its herbalists to help educate consumers on how adding Tollovid to their immune boosting strategy could potentially lead to improved outcomes in the face of circulating coronaviruses.
“Tollovid certainly is a unique asset in the botanical wellness space, and we are very pleased to be the first to bring this product to market in the United States,” said Lou Sagar, President & CEO of The Alchemist’s Kitchen. “It’s clear there has been a tremendous amount of science developed around Tollovid as it relates to 3CL inhibition, and we believe this could be an important mechanism during this critical time heading into the colder months of the year where people will congregate indoors more often. As a brand, The Alchemist’s Kitchen is always looking to be on the cutting edge of innovation in the botanical wellness space, and Tollovid certainly reinforces our market leading position.”
“We are excited to have selected the brand name Tollovid™ for NLC-001 and to be partnering with The Alchemist’s Kitchen to bring this important immune-boosting dietary supplement into the marketplace at this critical time in the United States,” said Gerald E. Commissiong, President & CEO of Todos Medical. “Some of the most promising data in the scientific literature to date in combatting coronaviruses has been generated by dietary supplements that help reinforce the body’s ability to respond to potential challenges from a coronavirus infection. We are targeting Tollovid to be added to this immune-boosting paradigm, and believe Tollovid could be an important part of an immune boosting strategy to help support and maintain a healthy immune system during this upcoming period of significant concern about potential circulating viruses heading into the colder weather months ahead.”
For information related to Todos Medical’s COVID-19 testing capabilities, please visit www.todoscovid19.com
For testing and PPE inquiries, please email sales@todosmedical.com.
About Tollovid™
Tollovid is an orally administered proprietary blend of plant extracts that includes a powerful 3CL protease inhibitor that helps support and maintain healthy immune function.
About The Alchemist’s Kitchen
The Alchemist's Kitchen is a plant-based wellness brand dedicated to the education of consumers to the potential benefits of botanical medicines and herbal remedies. It develops and markets proprietary formulations via retail and online channels of distribution. The Alchemist’s Kitchen flagship storefront is located at 119 Crosby St, New York, NY 10003. The Company’s website is www.thealchemistskitchen.com.
https://investor.todosmedical.com/news-events...supplement
